Mangoceuticals Launches TikTok Influencer Initiative and Becomes the Presenting Sponsor of the Only Stans Podcast with Glenny Balls
- Mangoceuticals launches new TikTok and Instagram Social Media Influencer Initiative to increase brand exposure
- Company aims to deepen its connection with Barstool Sports brand and Glenny Balls
- MangoRx plans to tap into Glenny Balls' audience reach to promote the brand
- Company ready to launch its presence on Instagram and TikTok with a series of new tier-one influencers
- None.
Announcement follows launch of Affiliate Program to Drive Further Awareness and Growth
Dallas, Texas, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ED) drug branded “Mango,” is excited to announce the official launch of the Company’s new TikTok and Instagram Social Media Influencer Initiative, featuring top relevant influencers with vast global fan bases on the world’s leading social media platforms.
After initial traction, the Company is ramping up its exposure by working to deepen its connection with the wildly popular Barstool Sports brand and Glenny Balls, famous American Podcaster, Blogger, TV personality, and Influencer on the Barstool Sports team as a top influencer. MangoRx has been a key sponsor of Barstool Sports podcasts since June 2023. This new step serves to deepen that relationship.
Furthermore, management notes that this is just the first step in the process of ramping up the Company’s footprint with leading relevant influencers on Instagram and TikTok.
Barstool Sports is one of the most widely followed influencer brands in the men’s health space, pulling in 15 million followers on Instagram and 33.3 million more on TikTok. Glenny Balls, through his own brand, has cultivated an audience of over 300k on Instagram and more than 243k on TikTok. In the immediate future, the Company will focus on tapping into Glenny Balls and his powerful audience reach to promote the MangoRx brand through the Old Row TikTok account (www.tiktok.com/@oldrowofficial).
“Our relationship with Barstool Sports and Glenny Balls is a powerful conduit to tap directly into our end market and connect with our most important cohort,” remarked Jacob Cohen, CEO and Co-Founder of MangoRx. “We are signing up leading influencers on the two most powerful social media platforms in the world right now and this is just the start. We are ready to launch our presence across these platforms at this point because our product line, our branding, and our messaging are all ready for that level of exposure. We plan to ramp up this facet of our marketing strategy aggressively going forward, with a series of new tier-one influencers coming on board over the following weeks. This is just the beginning.”
About Mango
Created using a special formulation featuring either the same active ingredient as in Cialis™ (Tadalafil) or Viagra™ (Sildenafil), each part of the Mango formulation plays a critical role in helping men achieve optimum performance. We believe the key to our success lies in our unique blend of ingredients, which are used in U.S. Food and Drug Administration (“FDA”) approved drugs. Mango contains a combination of either Sildenafil or Tadalafil along with Oxytocin and L-Arginine that have been traditionally used to treat sexual dysfunction.
Mango is a prescription medication that must be approved by a physician. After an individual has completed an online tele-health visit, our network of medical providers will review and approve a prescription if medically appropriate. Mango is a rapidly dissolved tablet (RDT) that is absorbed orally. For best results, we advise taking Mango at least 15 minutes before engaging in sexual activity. Sildenafil and Tadalafil, one of the main ingredients in Mango, typically have effects that last up to 4 and 36 hours, respectively.
About Mangoceuticals
Mangoceuticals, Inc. is a company focused on developing, marketing, and selling a variety of men's health and wellness products and services via a secure telemedicine platform. To date, the Company has identified men's wellness telemedicine services and products as a growing sector and especially related to the area of erectile dysfunction (ED). The Company has developed a new brand of ED product under the brand name "Mango" (think: "Man, Go!").
To participate in the Mango Revenue affiliate marketing program, please visit: https://mangorevenue.com.
For more information, please visit www.MangoRx.com.
Cautionary Note Regarding Forward-Looking Statements
Certain statements made in this press release contain forward-looking information within the meaning of applicable securities laws, including within the meaning of the Private Securities Litigation Reform Act of 1995 ("forward-looking statements"). These forward-looking statements represent the Company's current expectations or beliefs concerning future events and can generally be identified using statements that include words such as "estimate," "expects," "project," "believe," "anticipate," "intend," "plan," "foresee," "forecast," "likely," "will," "target" or similar words or phrases. These forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside of the Company's control which could cause actual results to differ materially from the results expressed or implied in the forward-looking statements, including, but not limited to; our ability to obtain additional funding and generate revenues to support our operations; risks associated with our ED product which have not been, and will not be, approved by the U.S. Food and Drug Administration ("FDA") and have not had the benefit of the FDA's clinical trial protocol which seeks to prevent the possibility of serious patient injury and death; risks that the FDA may determine that the compounding of our planned products does not fall within the exemption from the Federal Food, Drug, and Cosmetic Act ("FFDCA Act") provided by Section 503A; risks associated with related party relationships and agreements; the effect of data security breaches, malicious code and/or hackers; competition and our ability to create a well-known brand name; changes in consumer tastes and preferences; material changes and/or terminations of our relationships with key parties; significant product returns from customers, product liability, recalls and litigation associated with tainted products or products found to cause health issues; our ability to innovate, expand our offerings and compete against competitors which may have greater resources; our significant reliance on related party transactions; the projected size of the potential market for our technologies and products; risks related to the fact that our Chairman and Chief Executive Officer, Jacob D. Cohen and President, Jonathan Arango, combined have majority voting control over the Company; risks related to the significant number of shares in the public float, our share volume, the effect of sales of a significant number of shares in the marketplace, and the fact that the majority of our shareholders paid less for their shares than the public offering price of our common stock in our recent initial public offering; the fact that we have a significant number of outstanding warrants to purchase shares of common stock at
More information on potential factors that could affect the Company's financial results is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's filings with the SEC, including the Company’s Quarterly Report on Form 10-Q for the Quarter ended June 30, 2023. These filings are available at www.sec.gov and at our website at https://www.mangoceuticals.com/sec-filings. All subsequent written and oral forward-looking statements attributable to the Company or any person acting on behalf of the Company are expressly qualified in their entirety by the cautionary statements referenced above. Other unknown or unpredictable factors also could have material adverse effects on the Company's future results. The forward-looking statements included in this press release are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update these statements after the date of this release, except as required by law, and takes no obligation to update or correct information prepared by third parties that are not paid for by the Company. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.
Follow Mangoceuticals and MangoRx on social media:
https://www.instagram.com/mango.rx
https://twitter.com/Mangoceuticals
https://www.facebook.com/MangoRxOfficial
Or just click here to see why Orange is the new Blue:
https://www.mangorx.com
FOR PUBLIC RELATIONS
Lucky Break Public Relations
Sahra Simpson
Sahra@luckybreakpr.com
(323) 602-0091 ext. 704
FOR INVESTOR RELATIONS
Mangoceuticals Investor Relations
Email: investors@mangorx.com
MEDIA CONTACT
PHOENIX MGMT Marketing & Consulting
info@phoenix-mediamarketing.com
SOURCE: Mangoceuticals Inc.
![](https://ml.globenewswire.com/media/NDI2YzU1ZWUtZGM0Ni00ZTE2LWI3NjUtZWIyYWU4ZWMyODFlLTUwMDExNjEwNQ==/tiny/Mangoceuticals-Inc-.png)
FAQ
What is Mangoceuticals, Inc. announcing?
Who are the top influencers featured in the initiative?
How does MangoRx plan to promote the brand through TikTok?